Answers are grounded in this paper and cite their sources.
Controlled abstraction: [Ph3C][B(C6F5)4] is best known for its excellent ability to abstract alkyl ligands, however, the present study on mono(indenyl)–Sc–dialkyl/[Ph3C][B(C6F5)4] systems has found that [Ph3C][B(C6F5)4] can abstract a π-bonded indenyl ligand rather than a σ-alkyl ligand (see scheme). The abstraction pathway can be controlled by changing the substituents on the indenyl ligands.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: